Literature DB >> 14595150

Severe acute respiratory syndrome: radiographic evaluation and clinical outcome measures.

Clara G C Ooi1, Pek L Khong, James C M Ho, Bing Lam, Wai M Wong, Wai C Yiu, Poon C Wong, Chi F Wong, Kar N Lai, Kenneth W T Tsang.   

Abstract

PURPOSE: To evaluate the relationship among chest radiographs, oxygen supplementation requirement, and treatment response in severe acute respiratory syndrome (SARS).
MATERIALS AND METHODS: Forty patients (20 women, 20 men; mean age, 42.90 years +/- 14.01 [SD]; median age, 41.5 years; age range, 25-82 years) with SARS were evaluated. Daily chest radiographs were graded according to percentage of lung involvement during 20.15 days +/- 5.56 (median, 20 days; range, 14-38 days). Times between symptoms and treatment and time to reach maximal radiographic score from admission and treatment day were determined. Daily oxygen saturation (Sao2) and oxygen supplementation including mechanically assisted ventilation were recorded. Treatment response was defined as good, fair, and poor. Patterns of radiographic opacity at admission and at maximal radiographic score were noted. Differences in radiographic and clinical parameters with respect to oxygen supplementation and treatment response were respectively evaluated with Mann-Whitney and Kruskal-Wallis tests.
RESULTS: Larger maximal radiographic scores, lower Sao2 at maximal radiographic change, longer time from treatment to maximal radiographic score (P <.01), and diffuse consolidation at maximal radiographic score were associated with oxygen supplementation. Parameters that influenced treatment response were time from symptom onset to treatment day (P =.003), time from admission to treatment day (P <.001), time to maximal radiographic score from treatment day (P =.001), maximal radiographic score (P =.009), Sao2 at maximal radiographic score (P =.13), and treatment radiographic score (P =.03). Fair responders had shorter time between admission and treatment than did either good (P <.001) or poor responders (P =.002) and shorter time between symptoms and treatment (P <.001) and lower treatment radiographic score (P =.012) than did good responders. Good (82%), poor (36%), and fair (33%) responders developed maximal chest radiographic scores within 4 days of treatment (P =.008). Radiographic patterns at both admission and maximal radiographic score did not influence treatment response.
CONCLUSION: There are significant relationships among radiographic parameters, oxygen supplementation, and treatment response, and these relationships appear to be clinically useful in the treatment of SARS. Copyright RSNA, 2003

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14595150     DOI: 10.1148/radiol.2292030737

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  12 in total

1.  Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.

Authors:  Zhiwei Chen; Linqi Zhang; Chuan Qin; Lei Ba; Christopher E Yi; Fengwen Zhang; Qiang Wei; Tian He; Wenjie Yu; Jian Yu; Hong Gao; Xinming Tu; Agegnehu Gettie; Michael Farzan; Kwok-Yung Yuen; David D Ho
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

2.  Clinical, Laboratory, and Radiologic Manifestation of SARS.

Authors:  Kar Neng Lai; Kenneth W. Tsang; Wing Hong Seto; Clara G. C. Ooi
Journal:  Curr Infect Dis Rep       Date:  2004-06       Impact factor: 3.725

3.  Imaging Profile of the COVID-19 Infection: Radiologic Findings and Literature Review.

Authors:  Ming-Yen Ng; Elaine Y P Lee; Jin Yang; Fangfang Yang; Xia Li; Hongxia Wang; Macy Mei-Sze Lui; Christine Shing-Yen Lo; Barry Leung; Pek-Lan Khong; Christopher Kim-Ming Hui; Kwok-Yung Yuen; Michael D Kuo
Journal:  Radiol Cardiothorac Imaging       Date:  2020-02-13

Review 4.  Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)--possible lessons from a systematic review of SARS-CoV therapy.

Authors:  Hisham Momattin; Khurram Mohammed; Alimuddin Zumla; Ziad A Memish; Jaffar A Al-Tawfiq
Journal:  Int J Infect Dis       Date:  2013-08-29       Impact factor: 3.623

5.  Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome.

Authors:  Jung-Yien Chien; Po-Ren Hsueh; Wern-Cherng Cheng; Chong-Jen Yu; Pan-Chyr Yang
Journal:  Respirology       Date:  2006-11       Impact factor: 6.424

Review 6.  A review of treatment modalities for Middle East Respiratory Syndrome.

Authors:  Yin Mo; Dale Fisher
Journal:  J Antimicrob Chemother       Date:  2016-09-01       Impact factor: 5.790

7.  COVID-19 pneumonia: what has CT taught us?

Authors:  Elaine Y P Lee; Ming-Yen Ng; Pek-Lan Khong
Journal:  Lancet Infect Dis       Date:  2020-02-24       Impact factor: 25.071

8.  A correlation between the severity of lung lesions on radiographs and clinical findings in patients with severe acute respiratory syndrome.

Authors:  Yung-Liang Wan; Pei-Kwei Tsay; Yun-Chung Cheung; Ping-Cherng Chiang; Chun-Hua Wang; Ying-Huang Tsai; Han-Ping Kuo; Kuo-Chien Tsao; Tzou-Yien Lin
Journal:  Korean J Radiol       Date:  2007 Nov-Dec       Impact factor: 3.500

9.  Associations between CT pulmonary opacity score on admission and clinical characteristics and outcomes in patients with COVID-19.

Authors:  Huanyuan Luo; Yuancheng Wang; Songqiao Liu; Ruoling Chen; Tao Chen; Yi Yang; Duolao Wang; Shenghong Ju
Journal:  Intern Emerg Med       Date:  2021-06-30       Impact factor: 5.472

Review 10.  SARS: radiological features.

Authors:  Gaik Cheng Ooi; Ma Daqing
Journal:  Respirology       Date:  2003-11       Impact factor: 6.424

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.